Sildenafil Is More Selective Pulmonary Vasodilator Than Prostaglandin E1 in Patients With Pulmonary Hypertension Due to Heart Failure

April 2011
Physiological Research;2011, Vol. 60 Issue 2, p303
Academic Journal
No abstract available.


Related Articles

  • Pulmonary Hemodynamic Responses to Intravenous Prostaglandin E2 in Broiler Chickens. Stebel, S.; Wideman, R. F. // Poultry Science;Jan2008, Vol. 87 Issue 1, p138 

    Prostaglandin E2 (PGE2) affects pulmonary arterial pressure (PAP), pulmonary vascular resistance (PVR), and respiratory rate (RR) in mammals, but no information previously was available regarding avian pulmonary responses to PGE2. Two experiments were conducted in which 45- to 55-d-old male...

  • Safety and efficacy of bosentan in paediatric patients with pulmonary arterial hypertension: retrospective case series.  // Cardiology in the Young;May2005 Supplement 2, Vol. 15 Issue S2, p77 

    The article focuses on a study related to the safety and efficacy of bosentan in paediatric patients with pulmonary arterial hypertension. In paediatric patients, 12-week bosentan treatment in 19 children aged 3-15 years resulted in haemodynamic improvement and was well tolerated. Paediatric...

  • News Update.  // Urology Times;Nov2007, Vol. 35 Issue 14, p6 

    The article offers news briefs related to urology in the U.S. A study has found that the presence of a third group of highly disorganized Gleason 5 cells in a prostate cancer biopsy identifies aggressiveness disease in men. A new drug application has been submitted by NexMed Inc. to the Food and...

  • Suppressive Effect of Prostaglandin E[sub 1] on Pulmonary Hypertension Induced by Monocrotaline... Sakuma, F.; Miyata, M.; Kasukawa, R. // Lung;1999, Vol. 177 Issue 2, p77 

    Studies the effect of prostaglandin E[sub 1] on monocrotaline-induced pulmonary hypertension and cytokine production by macrophages during the monocrotaline induction of pulmonary hypertension. Effectiveness of administering prostaglandin E[sub 1] in the treatment of some forms of pulmonary...

  • Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate. Montorsi, F.; Althof, S.E.; Sweeney, M.; Menchini-Fabris, F.; Sasso, F.; Giuliano, F. // International Journal of Impotence Research;Dec2003, Vol. 15 Issue 6, p444 

    Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at...

  • Vasodilators and Prostaglandin Inhibitors in Primary Pulmonary Hypertensions. Hermiller, James B.; Bambach, Dennis; Thompson, Michael J.; Huss, Patricia; Fontana, Mary E.; Magorien, Raymond D.; Unverferth, Donald V.; Leier, Carl V. // Annals of Internal Medicine;Oct82, Vol. 97 Issue 4, p480 

    Deals with a study which determined and compared the resting hemodynamic effects of various vasodilator agents and prostaglandin inhibitors in patients with primary pulmonary hypertension. Background on primary pulmonary hypertension; Patient population; Baseline hemodynamic data; Discussion...

  • Therapy.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 2, p55 

    A review of several articles including "Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study," by L. J. Rubin, D. B. Badesch, and T. R. Fleming, "Combination therapy in pulmonary arterial hypertension: A meta-analysis," by Y. Bai, L. Sun, and S. Hu,...

  • Sildenafil and Exercise Capacity in Heart Failure. Abrams, Jonathan // Clinical Cardiology Alert;Dec2007, Vol. 26 Issue 12, p93 

    An interesting therapeutic concept that has been put into clinical practice in the past several years is the use of nitric oxide donors for pulmonary hypertension. This report assesses subjects with significant pulmonary hypertension and with severe left ventricular failure and right ventricular...

  • The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension. Sharif-kashani, Babak; Hamraghani, Ali; Salamzadeh, Jamshid; Nazari, Mohammad Abbasi; Malekmohammad, Majid; Behzadnia, Neda; Fahimi, Fanak // Iranian Journal of Pharmaceutical Research;2014 Supplement, Vol. 13, p161 

    Pulmonary hypertension (PH) is an important cause of heart failure in chronic obstructive pulmonary disease (COPD). The pro brain natriuretic peptide N-terminal (NT-proBNP) has been suggested as a noninvasive marker to evaluate ventricular function. However, there is no evidence to support the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics